CareDx, Inc. Hits New 52-Week High of $26.26, Up 75.47%

CareDx, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 26.26 on June 18, 2026. This achievement underscores the company's robust performance over the past year, with a remarkable increase of 75.47%, significantly outpacing the S&P 500's growth of 25.41% during the same period. The company's financial metrics reflect a strong operational turnaround, highlighted by a staggering 426.01% growth in operating profit reported on March 26. CareDx has consistently delivered positive results for three consecutive quarters, showcasing its ability to enhance profitability. The operating cash flow reached its highest at USD 72.95 million, while pre-tax profit and net profit for the latest quarter grew by 204.24% and 203.07%, respectively. With a market capitalization of USD 859 million and a debt-to-equity ratio of -0.56, CareDx demonstrates a solid financial position. The company’s price-to-book ratio stands at 2.84, indicating a favorable valuation in the current market landscape.